Bratislav Janjic

896 total citations
16 papers, 746 citations indexed

About

Bratislav Janjic is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Bratislav Janjic has authored 16 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 9 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Bratislav Janjic's work include Immunotherapy and Immune Responses (11 papers), T-cell and B-cell Immunology (8 papers) and vaccines and immunoinformatics approaches (6 papers). Bratislav Janjic is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), T-cell and B-cell Immunology (8 papers) and vaccines and immunoinformatics approaches (6 papers). Bratislav Janjic collaborates with scholars based in United States, France and Serbia. Bratislav Janjic's co-authors include John M. Kirkwood, Hassane M. Zarour, Nikola L. Vujanović, Walter J. Storkus, Ganwei Lu, Theresa L. Whiteside, Julien Fourcade, Jelena M. Janjic, Arthur Μ. Krieg and Cindy Sander and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Frontiers in Immunology.

In The Last Decade

Bratislav Janjic

15 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bratislav Janjic United States 11 564 302 259 36 35 16 746
Maxime Dhainaut United States 7 436 0.8× 335 1.1× 240 0.9× 54 1.5× 43 1.2× 12 707
Mai-Britt Zocca Denmark 15 509 0.9× 348 1.2× 268 1.0× 57 1.6× 18 0.5× 25 718
Christie Fanton United States 11 267 0.5× 288 1.0× 198 0.8× 36 1.0× 34 1.0× 26 587
Amanda L. Vegoe United States 7 677 1.2× 146 0.5× 182 0.7× 40 1.1× 53 1.5× 7 869
Monika Kusio-Kobiałka Poland 10 360 0.6× 404 1.3× 258 1.0× 30 0.8× 36 1.0× 15 761
Erica Lantelme Italy 15 429 0.8× 184 0.6× 281 1.1× 74 2.1× 39 1.1× 25 742
Heba Nowyhed United States 12 670 1.2× 274 0.9× 179 0.7× 61 1.7× 37 1.1× 17 867
Catherine Matte-Martone United States 17 544 1.0× 235 0.8× 170 0.7× 43 1.2× 58 1.7× 27 861
María Alejandra Gleisner Chile 15 310 0.5× 212 0.7× 298 1.2× 44 1.2× 21 0.6× 24 620
Andreas Bonertz Germany 12 599 1.1× 443 1.5× 163 0.6× 45 1.3× 31 0.9× 24 883

Countries citing papers authored by Bratislav Janjic

Since Specialization
Citations

This map shows the geographic impact of Bratislav Janjic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bratislav Janjic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bratislav Janjic more than expected).

Fields of papers citing papers by Bratislav Janjic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bratislav Janjic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bratislav Janjic. The network helps show where Bratislav Janjic may publish in the future.

Co-authorship network of co-authors of Bratislav Janjic

This figure shows the co-authorship network connecting the top 25 collaborators of Bratislav Janjic. A scholar is included among the top collaborators of Bratislav Janjic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bratislav Janjic. Bratislav Janjic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Janjic, Bratislav, Aditi Kulkarni, Robert L. Ferris, Lazar Vujanović, & Nikola L. Vujanović. (2022). Human B Cells Mediate Innate Anti-Cancer Cytotoxicity Through Concurrent Engagement of Multiple TNF Superfamily Ligands. Frontiers in Immunology. 13. 837842–837842. 13 indexed citations
2.
Liu, Lu, Hüseyi̇n Karagöz, Fatih Zor, et al.. (2020). Sex Differences Revealed in a Mouse CFA Inflammation Model with Macrophage Targeted Nanotheranostics. Theranostics. 10(4). 1694–1707. 33 indexed citations
3.
Fourcade, Julien, Ahmad A. Tarhini, Stergios J. Moschos, et al.. (2020). PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen-Specific CD8+ T Cells Induced by Melanoma Vaccines. UNC Libraries.
4.
Janjic, Jelena M., et al.. (2016). NIR and MR imaging supported hydrogel based delivery system for anti-TNF alpha probiotic therapy of IBD. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 6 indexed citations
5.
Fourcade, Julien, Zhaojun Sun, Ornella Pagliano, et al.. (2013). PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen–Specific CD8+ T Cells Induced by Melanoma Vaccines. Cancer Research. 74(4). 1045–1055. 175 indexed citations
6.
Pascucci, Barbara, Egidio Iorio, Sara Giovannini, et al.. (2012). An altered redox balance mediates the hypersensitivity of Cockayne syndrome primary fibroblasts to oxidative stress. Aging Cell. 11(3). 520–529. 83 indexed citations
7.
Fourcade, Julien, Zhaojun Sun, Pavol Kudela, et al.. (2010). Human Tumor Antigen-Specific Helper and Regulatory T Cells Share Common Epitope Specificity but Exhibit Distinct T Cell Repertoire. The Journal of Immunology. 184(12). 6709–6718. 36 indexed citations
8.
Kudela, Pavol, Zhaojun Sun, Julien Fourcade, et al.. (2010). Epitope Hierarchy of Spontaneous CD4+ T Cell Responses to LAGE-1. The Journal of Immunology. 186(1). 312–322. 6 indexed citations
9.
Fourcade, Julien, Pavol Kudela, Pedro A. Andrade Filho, et al.. (2008). Immunization With Analog Peptide in Combination With CpG and Montanide Expands Tumor Antigen-specific CD8+ T Cells in Melanoma Patients. Journal of Immunotherapy. 31(8). 781–791. 90 indexed citations
10.
Kudela, Pavol, Bratislav Janjic, Julien Fourcade, et al.. (2007). Cross-Reactive CD4+ T Cells against One Immunodominant Tumor-Derived Epitope in Melanoma Patients. The Journal of Immunology. 179(11). 7932–7940. 6 indexed citations
11.
Janjic, Bratislav, Xiaofei Wang, Julien Fourcade, et al.. (2006). Spontaneous CD4+ T Cell Responses against TRAG-3 in Patients with Melanoma and Breast Cancers. The Journal of Immunology. 177(4). 2717–2727. 15 indexed citations
12.
Mandić, Maja, Florence Castelli, Bratislav Janjic, et al.. (2005). One NY-ESO-1-Derived Epitope That Promiscuously Binds to Multiple HLA-DR and HLA-DP4 Molecules and Stimulates Autologous CD4+ T Cells from Patients with NY-ESO-1-Expressing Melanoma. The Journal of Immunology. 174(3). 1751–1759. 57 indexed citations
13.
Zarour, Hassane M., Maja Mandić, Pavol Kudela, et al.. (2005). Randomized Phase I-II Study of Vaccination With CpG 7909, Montanide ISA 720 and NY-ESO-1 Peptides for Patients With Stage III/IV Melanoma and NY-ESO-1+ Tumors: An Interim Analysis. Journal of Immunotherapy. 28(6). 661–662. 1 indexed citations
14.
Mandić, Maja, Christine Almunia, Daniel Gillet, et al.. (2003). The alternative open reading frame of LAGE-1 gives rise to multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type tumor-reactive CD4+ T cells.. PubMed. 63(19). 6506–15. 34 indexed citations
15.
Janjic, Bratislav, et al.. (2002). Innate Direct Anticancer Effector Function of Human Immature Dendritic Cells. I. Involvement of an Apoptosis-Inducing Pathway. The Journal of Immunology. 168(4). 1823–1830. 79 indexed citations
16.
Lu, Ganwei, Bratislav Janjic, Jelena M. Janjic, et al.. (2002). Innate Direct Anticancer Effector Function of Human Immature Dendritic Cells. II. Role of TNF, Lymphotoxin-α1β2, Fas Ligand, and TNF-Related Apoptosis-Inducing Ligand. The Journal of Immunology. 168(4). 1831–1839. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maxime Dhainaut Breakdown of academic impact, for papers by Mai-Britt Zocca Breakdown of academic impact, for papers by Christie Fanton Breakdown of academic impact, for papers by Amanda L. Vegoe Breakdown of academic impact, for papers by Monika Kusio-Kobiałka Breakdown of academic impact, for papers by Erica Lantelme Breakdown of academic impact, for papers by Heba Nowyhed Breakdown of academic impact, for papers by Catherine Matte-Martone Breakdown of academic impact, for papers by María Alejandra Gleisner Breakdown of academic impact, for papers by Andreas Bonertz
Rankless by CCL
2026